Abselion, a pioneering life sciences technology company headquartered in Cambridge, UK, dedicated to streamlining biomolecule quantification, has announced the strategic…
Read More

Abselion, a pioneering life sciences technology company headquartered in Cambridge, UK, dedicated to streamlining biomolecule quantification, has announced the strategic…
Read More
Salk Institute researchers have pinpointed a crucial protein, Med14, that acts as a molecular bridge connecting GLP-1 agonist drugs to…
Read More
As the global population undergoes a profound demographic shift toward an older age profile, the prevalence of age-related physical decline…
Read More
The landscape of neurodegenerative research has been significantly altered by a collaborative breakthrough from scientists at UCLA Health and the…
Read More
Researchers from a consortium of leading international institutions have unveiled groundbreaking insights into the intricate life cycle of the malaria…
Read More
The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy in…
Read More
Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…
Read More
A collaborative research team at the Texas Children’s Duncan Neurological Research Institute (NRI) and Baylor College of Medicine has unveiled…
Read More
A multi-institutional research team led by Osaka University has identified a critical protein-to-protein interaction that serves as a master regulator…
Read More
A landmark study published in Molecular Psychiatry has unveiled a specific biochemical pathway that may explain the underlying neurobiology of…
Read More